Improvement of real-time polymerase chain reaction for quantifying TNF-α mRNA expression in inflamed colorectal mucosa: An approach to optimize procedures for clinical use

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 66, Issue 3, 2006, Pages 249-259

  Cui, G ^a   Olsen, T ^a   Christiansen, I ^a   Vonen, B ^b   Florholmen, J ^a   Goll, R ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Crohn's disease; Real time polymerase chain reaction; Taqman; Tumor necrosis factor alpha; Ulcerative colitis

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLON BIOPSY; COLON MUCOSA; COLORECTAL DISEASE; CONTROLLED STUDY; CROHN DISEASE; DNA SYNTHESIS; HUMAN; HUMAN TISSUE; INFLAMMATION; MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECTUM BIOPSY; RECTUM MUCOSA; REPRODUCIBILITY; RNA DEGRADATION; ULCERATIVE COLITIS;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745728425     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510600590472     Document Type: Article

References (26)

1. Ganesan S, Travis SP, Ahmad T, Jazrawi R. Role of tumor necrosis factor in Crohn's disease. Curr Opin Investig Drugs 2002;3:1297-300.
2. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
3. Inoue S, Matsumoto T, Iida M, Mizuno M, Kuroki F, Hoshika K, et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity. Am J Gastroenterol 1999;94:2441-6.
4. Sands BE. Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:323-51.
5. Sandborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 2005;5:10-8.
6. Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 2004;19:308-15.
7. Kusigami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci 1995;40:949-59.
8. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992;33:1214-9.
9. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:2725-9.
10. Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T, Arakawa T. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int J Mol Med 2003;11:175-9.
11. Blaschke V, Reich K, Blaschke S, Zipprich S, Neumann C. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods 2000;246:79-90.
12. Stordeur P, Poulin LF, Craciun L, Zhou L, Schandene L, de Lavareille A, et al. Cytokine mRNA quantification by real-time PCR. J Immunol Methods 2002;259:55-64.
13. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001;25:386-401.
14. Bas A, Forsberg G, Hammarstrom S, Hammarstrom ML. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate- dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 2004;59:566-73.
15. Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond) 2005;109:365-79.
16. Träger C, Kongner P, Lindskog M, Ponthan F, Kullman A, Kågedal B. Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow. Clin Chem 2003;49:104-12.
17. Kågedal B, Kullman A, Lenner L, Träger C, Kongner P, Franebäck M. Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells. Pigment Cell Res 2004;17:346-51.
18. Marx V. RNA quality: defining the good, the bad, and the ugly. Genomics Proteomics 2004;5:14-8.
19. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002;29:23-39.
20. Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee RY, et al. Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Clin Cancer Res 2002;8:1155-66.
21. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 2004;26:509-15.
22. Silva MA, Menezes J, Wizman S, Gendron R, Oligny L, Seidman EG. Cytokine tissue levels as markers of disease activity in pediatric Crohn disease. Pediatr Res 2003;54:456-61.
23. Johansson M, Takasaki A, Lenner L, Årstrand K, Kågedal B. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines. Melanoma Res 2002;12:193-200.
24. Overbergh L, Valckx D, Waer M, Mathieu C. Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR. Cytokine 1999;11:305-12.
25. Gentle A, Anastasopoulos F, McBrien NA. High-resolution semi-quantitative real-time PCR without the use of a standard curve. Biotechniques 2001;31:502, 504-6, 508.
26. Ochsenkuhn T, Sackmann M, Goke B. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol 2004;16:1167-71.